Stated purpose: Rhabdomyosarcomas are a heterogeneous group of malignant tumors representing the most common soft tissue sarcoma in lower genitourinary tract mostly occurs in infants and children in the first 2 decades of life. It is a rare and potentially deadly malignant mesenchymal neoplasia mainly originating from immature striated muscle. Rhabdomyosarcoma cells tend to appear rod-shaped, having an identifiable striated muscular differentiation with rhabdomyoblasts cells. Clinical guidelines and treatment of these tumors are very difficult because rhabdomyosarcomas behave extremely different and requires an early diagnosis and therapeutic modalities involving surgery, chemotherapy and radiation therapy.
Material & Methods:In the present study, the authors report a rare case of Grade-II Penile Rhabdomyosarcoma diagnosed in a 2-year male child and have explored the histopathological literature and treatment options for this rare entity.
Conclusion:We summarized the results from the available data to the published findings which have recently reported for the proven case of grade-II rhabdomyosarcoma of the penis with treatment options for this rare entity. Considering the limited number of cases reported till now, the conclusions about treatment and prognosis are equivocal. Finally the authors concluded that penile sarcomas are rare tumors with poor prognosis when they involve deep-seated lesions.Keywords: Penile rhabdomyosarcoma; Mesenchymal neoplasia; Neoplasm metastasis histopathological appearance and immunohistochemical profile of the biopsy tissue confirmed it to be a grade-II rhabdomyosarcoma of the penis.With this diagnosis, the patient underwent nine cycles of three weekly intravenous neo-adjuvant chemotherapy with VAC i.e. Inj Vincristine 7 mg, Inj Doxorubicin 20 mg and Inj Cyclophosphamide 200 mg. Initially patient showed good regression up to 6-cycles of VAC chemotherapy but the tumor was still unresectable and hence it was decided to give 3-more courses of VAC, however later the tumor has progressed and in view of the inoperable size of the tumor, it was decided to give second line three weekly intravenous combination chemotherapy with Inj Carboplatin 150 mg and Inj Etoposide 50 mg. Despite three cycles of 2nd line chemotherapy, the disease was progressive and inoperable and the patient further developed multiple lung metastases as reported in MRI chest and abdomen in form of round lesions seen in bilateral lung peripheries. Patient later left the hospital follow-up. Figure 4C) and Vimentin ( Figure 4D).
Results and DiscussionRhabdomyosarcoma is an exceedingly rare and highly malignant tumor of childhood with a typical locally invasive neoplasm that accounts for 3.8% of solid tumors in children [4][5][6]. The diagnosis of RMS can be difficult with conventional histological techniques and extensive immunocytochemical staining is strongly recommended to establish the diagnosis. Prognostic factors include mainly lesion size (larger or smaller than 5 cm), extension of invasion (superficial...